Symptomatic therapy is the cornerstone of membranous nephropathy treatment in the elderly, with immunosuppressive therapy reserved for high-risk patients

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.24, Iss.8, 2008-08, pp. : 9-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 7, 2010-07 ,pp. : 17-20

Adis International

Access to resources Recommend Favorite

Dual antiplatelet therapy: no added benefits for high-risk patients

By  

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Combination Delapril/Manidipine as Antihypertensive Therapy in High-Risk Patients

By Fogari Roberto  

Clinical Drug Investigation, Vol. 31, Iss. 7, 2011-07 ,pp. : 439-453

Adis International

Access to resources Recommend Favorite

High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy

By Eastham James A  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 291-295

Informa Healthcare

Access to resources Recommend Favorite

Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer

By Eastham James A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 39-46

Informa Healthcare

Access to resources Recommend Favorite